Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 1/20 | 0.75 |
| ▸ | CNR1 | P21554 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | NAAA | Q02083 | 1/20 | 0.71 |
| ▸ | FAAH | O00519 | 5/20 | 0.69 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.68 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.65 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.65 |
| ▸ | CNR2 | P34972 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Palmidrol SCHEMBL120518 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL7858023 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL679082 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL12972842 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL7942314 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL308261 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL308683 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL9425227 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL21357244 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL232840 | 1.00 | SELP (0.75) | SELPCNR1ALDH1A1HPGDTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-03-06 | — | — | US | claimed |
| EP-4378921-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (CN) | 2024-06-05 | — | — | EP | claimed |
| US-20220290200-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS | OCTARINE BIO IVS (DK) | 2022-09-15 | — | — | US | claimed |
| EP-3976769-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS | Octarine Bio IVS (DK) | 2022-04-06 | — | — | EP | claimed |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250361537-A1 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | TRAIT BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-12465628-B2 | Cannabinoid carrier compositions having enhance pharmacokinetic properties and methods of use thereof | DESERT HARVEST, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| US-12397061-B2 | Systems, methods, and compositions for the generation of water-soluble cannabinoids utilizing fatty-acid binding proteins and fatty-acid binding-like proteins as cannabinoid-carriers | TRAIT BIOSCIENCES, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378586-B2 | Systems, methods, and compositions for the glycosylation of cannabinoid compounds | TRAIT BIOSCIENCES, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2025-03-06 | — | — | US | disclosed |
| US-20240226075-A1 | CANNABIS PRODUCTION SYSTEMS AND METHODS | INSECTERGY US LLC | 2024-07-11 | — | — | US | disclosed |
| US-8592117-B2 | Toner and developer | RICOH COMPANY, LTD. (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20120189951-A1 | TONER AND DEVELOPER | RICOH COMPANY, LTD. (JP) | 2012-07-26 | — | — | US | disclosed |
| US-8227164-B2 | Toner, and developer, developer container, process cartridge, image forming apparatus and image forming method using the toner | RICOH COMPANY, LIMITED (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110076607-A1 | TONER, DEVELOPER, TONER ACCOMMODATING CONTAINER, PROCESS CARTRIDGE AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-2296044-A1 | Toner, and developer, developer container, process cartridge, image forming apparatus and image forming method using the toner | Ricoh Company, Ltd. (JP) | 2011-03-16 | — | — | EP | disclosed |
| EP-2279456-A1 | TONER, DEVELOPER, TONER ACCOMMODATING CONTAINER, PROCESS CARTRIDGE AND IMAGE FORMING METHOD | Ricoh Company, Ltd. (JP) | 2011-02-02 | — | — | EP | disclosed |
| US-20100310980-A1 | TONER, AND DEVELOPER, DEVELOPER CONTAINER, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS AND IMAGE FORMING METHOD USING THE TONER | RICOH COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
| WO-2009142338-A1 | TONER, DEVELOPER, TONER ACCOMMODATING CONTAINER, PROCESS CARTRIDGE AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250073255-A1 | USE OF FA-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | FABP2, FABP1, FASN | SELP 3547/4885CNR1 3695/4885ALDH1A1 3025/4885 |
| US-20240226075-A1 | CANNABIS PRODUCTION SYSTEMS AND METHODS | CNR2, CNR1, CDIPT | SELP 4473/4885CNR1 2/4885ALDH1A1 4844/4885 |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | DHCR24, CNR2, DSG1 | SELP 4850/4885CNR1 6/4885ALDH1A1 1504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.